NCT04068753
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04068753
Title Niraparib in Combination With TSR-042 in Patients With Recurrent or Progressive Cervix Cancer (STAR)
Acronym STAR
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Oklahoma
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.